Samsung Galaxy Tab S10 wishlist: All the features I want to see

The Samsung Galaxy Tab S9 series ranks as the best trio of Android tablets, but nothing is perfect. The extremely wide aspect ratio is one of the most obvious weaknesses for anyone hoping to use the tablets in portrait orientation, but there are other improvements we’d love to see, too. While we likely won’t see a new model until late 2024, it’s fun to speculate what the Samsung Galaxy Tab S10, Tab S10 Plus, and Tab S10 Ultra might have in store for us. Let’s jump right in and take a look at my wishlist for Samsung’s 2024 flagship tablet.

Optional 5G for the entire Tab S10 lineup

The Samsung Galaxy Tab S9 Plus is the only model that offers a 5G option. That’s right; if you want the Tab S9 or Tab S9 Ultra, your only choice is a Wi-Fi-only model. This seems like a silly oversight, especially for the Ultra, which has a large display that could make it a great travel companion for those who need something that can double as a monster productivity machine. I really think all the Galaxy Tab S10 models should have 5G as an option. I can’t see it adding much to the production costs, so it feels like a low-risk change for Samsung.



from Android Authority https://ift.tt/Bl4pXHv
via IFTTT

Comments

Post a Comment

Popular posts from this blog

6 investors discuss why AI is more than just a buzzword in biotech

As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. “Most of the companies we have seen have an AI component to support the discovery or development processes,” Francisco Dopazo, a general partner at Humboldt Fund told TechCrunch recently. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations. So to get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today. For Franck Lescure, a partner at Elaia Partners, in biotech, having an AI component isn’t an automatic deal closer. “We do not favor biotech startups with extant AI over those without: Bio-revolution is not only digital. Digital is one tool; the other major tool is the livin
Read more

Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures (Igor Bosilkovski/Forbes)

Image
Igor Bosilkovski / Forbes : Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures   —  Canadian collaborative conversational AI tool Voiceflow announced today that it has raised $20 million in a Series A round led by Felicis Ventures. from Techmeme https://ift.tt/3rFQ9St via IFTTT
Read more

Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics (Adam Rawnsley/Rolling Stone)

Image
Adam Rawnsley / Rolling Stone : Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics   —  Elon's mass firing of security staff and increased reliance on automation is going to make it easier for tyrants to shout … from Techmeme https://ift.tt/xQsF2ef via IFTTT
Read more